Cardiovascular disease risk and comparison of different strategies for blood pressure management in rural India 11 Medical and Health Sciences 1102 Cardiorespiratory Medicine and Haematology 11 Medica. BMC Public Health. 2018;18. doi:10.1186/s12889-018-6142-x.
Cardiovascular disease risk and comparison of different strategies for blood pressure management in rural India. BMC Public Health. 2018;18:1264. doi:10.1186/s12889-018-6142-x.
Elevated blood pressure and risk of aortic valve disease: A cohort analysis of 5.4 million UK adults. European Heart Journal. 2018;39:3596 - 3603. doi:10.1093/eurheartj/ehy486.
Elevated blood pressure and risk of mitral regurgitation: A longitudinal cohort study of 5.5 million United Kingdom adults. PLoS Med. 2017;14(10):e1002404. doi:10.1371/journal.pmed.1002404.
The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials. Cardiovasc Drugs Ther. 2017;31(4):391-400. doi:10.1007/s10557-017-6747-9.
Gender inequalities in cardiovascular risk factor assessment and management in primary healthcare. Heart. 2017;103(7):492-498. doi:10.1136/heartjnl-2016-310216.
From Telemedicine to Wearables: The Impact of Technological Innovations on Global Health. Topic: Systematic Medical Appraisal, Referral and Treatment for NCDs. In: Winter Meeting Clinton Global Initiative. Winter Meeting Clinton Global Initiative. New York, USA; 2016..
Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet. 2016;388(10059):2532-2561. doi:10.1016/S0140-6736(16)31357-5.
The Effects of a Community-Based Sodium Reduction Program in Rural China - A Cluster-Randomized Trial. PLoS One. 2016;11:e0166620.
Usual blood pressure, atrial fibrillation and vascular risk: evidence from 4.3 million adults. International Journal of Epidemiology. 2016.
Prevention and Control of Cardiovascular Disease in the Rapidly Changing Economy of China. Circulation. 2016;133:2545-60..
Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON. Diabetes Care. 2016;pii: dc152322. .
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. Lancet. 2015;387:435-443.
Major surgery in south India: a retrospective audit of hospital claim data from a large community health insurance programme. Lancet. 2015;385 Suppl 2:S23.
A user-centred home monitoring and self-management system for patients with heart failure: A multi-centre cohort study.; 2015.
Effect of a computer-guided, quality improvement program for cardiovascular disease risk management in primary health care: the treatment of cardiovascular risk using electronic decision support cluster-randomized trial. 2015;8:87-95.
Use of major surgery in south India: A retrospective audit of hospital claim data from a large, community health insurance program. Surgery. 2015;157:865-73.
Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus: results from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation. Hypertension. 2015;65:115-21.
The epidemiology of blood pressure and its worldwide management. Circulation Research. 2015;116:925-36..
SMARTHealth India: Development and Field Evaluation of a Mobile Clinical Decision Support System for Cardiovascular Diseases in Rural India. JMIR Mhealth Uhealth. 2014;2:e54.
Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet. 2014;384:591-8.
Risk prediction in patients with heart failure: a systematic review and analysis. JACC Heart Failure. 2014;2:440-6.
The incidence and clinical predictors of ACE-inhibitor induced dry cough by perindopril in 27,492 patients with vascular disease. International Journal of Cardiology. 2014;176(3):718-23.
Degree of blood pressure reduction and recurrent stroke: the PROGRESS trial. Journal of Neurology, Neurosurgery, and Psychiatry. 2014;pii: jnnp-2014-307856.